USA Herald – Novavax has landed a major pharmaceutical partnership after signing a new vaccine technology licensing agreement with Pfizer, a move that sent the biotech company’s shares sharply higher ...
Novavax said on Tuesday it signed a licensing agreement allowing Pfizer access to its technology that boosts immune responses to vaccines for use in up to two infectious diseases, and the smaller co...
